From Casetext: Smarter Legal Research

Sigmapharm, Inc. v. Mutual Pharmaceutical Company, Inc.

United States District Court, E.D. Pennsylvania
Mar 2, 2011
CIVIL NO. 10-430 (E.D. Pa. Mar. 2, 2011)

Opinion

CIVIL NO. 10-430.

March 2, 2011


ORDER


AND NOW, this 2nd day of March 2011, upon consideration of a Motion to Dismiss Counts I through III by Defendant King Pharmaceuticals, Inc. [doc. no. 40] and a Motion to Dismiss all Counts by Defendants Mutual Pharmaceuticals Company, Inc. and United Research Laboratories, Inc.[doc. no. 41]; Plaintiff's Responses in Opposition thereto [doc. nos. 42 43]; and Defendants Replies in Support [doc. nos. 49 51]; and for the reasons stated in the accompanying Memorandum Opinion, it is hereby ORDERED that:

1. Count I is DISMISSED without prejudice for failure to state a claim pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure; and

2. The remaining claims, Counts II, III and IV, are DISMISSED without prejudice pursuant to 28 U.S.C. § 1367(c)(3).

3. Defendants' Motion to Stay Discovery [doc. no. 44] and Plaintiff's Motion to Compel Discovery [doc. no. 57] are DISMISSED as moot.

It is so ORDERED.


Summaries of

Sigmapharm, Inc. v. Mutual Pharmaceutical Company, Inc.

United States District Court, E.D. Pennsylvania
Mar 2, 2011
CIVIL NO. 10-430 (E.D. Pa. Mar. 2, 2011)
Case details for

Sigmapharm, Inc. v. Mutual Pharmaceutical Company, Inc.

Case Details

Full title:SIGMAPHARM, INC., Plaintiff, v. MUTUAL PHARMACEUTICAL COMPANY, INC., et…

Court:United States District Court, E.D. Pennsylvania

Date published: Mar 2, 2011

Citations

CIVIL NO. 10-430 (E.D. Pa. Mar. 2, 2011)